Power Over Pain

Find Buzzy & VibraCool at shop.paincarelabs.comThe warmer weather is helping to reduce Covid spread (above 48 degrees Fahrenheit.) Moderna and Pfizer vaccines for teens are proving to be 100% effective. Vaccines are proving effective against existing variants.What should we be doing now?We should be changing our ventilation going forward for this pandemic and future ones. Use UV light, replace old units that don't circulate.Dedicated COVID-19 webpage here: https://explore.paincarelabs.com/covid-19-vaccination-resourcesBuzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections, and the temporary relief of minor injuries (muscle or tendon aches, splinters, and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion, and muscle tension.Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.

Find Buzzy & VibraCool at shop.paincarelabs.comThose who got Covid had levels of immunity 10x lower than those who had been vaccinated, certainly if one catches only a mild case. Those who got covid and then got vaccinated compared to those who were just vaccinated, the protection against variants was higher in those who had covid.Healthcare workers, especially frontline healthcare workers, got infected with covid got infected less than expected, but neonatologists did not. Those who had been seeing decades of disease exposure had immunity that helped with covid, whereas the neonatologists around more sterile environments and patients were more likely to get sick.No answer yet as to why Pfizer made the cutoff 12 years old instead of going younger. Moderna is going through trials right now for children, so the odds of a vaccine for younger kids are hopeful.Dedicated COVID-19 webpage here: https://explore.paincarelabs.com/covid-19-vaccination-resourcesBuzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections, and the temporary relief of minor injuries (muscle or tendon aches, splinters, and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion, and muscle tension.Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.

Dr. Baxter talks about new data on pediatric vaccination efficacy, the impact of strains going forward, and she gives an update on her nasal irrigation study.Find Buzzy & VibraCool at shop.paincarelabs.comDedicated COVID-19 webpage here: https://explore.paincarelabs.com/covid-19-vaccination-resourcesBuzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections, and the temporary relief of minor injuries (muscle or tendon aches, splinters, and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion, and muscle tension.Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.

Find Buzzy & VibraCool at shop.paincarelabs.comFirst, Dr. Baxter talks about how all the normal safety and efficacy procedures were followed as with normal FDA vaccine processes, it's only more background information and subgroup testing that were deprioritized to save time.Fainting and embarrassment about fainting are not directly tied to needle fear. Those who were afraid of fainting were much more likely to choose the J&J one-shot vaccine given all options - so J&J sites self-select for a more fainty crowd. Tip: drink 16 oz of a caffeinated drink one hour before, and don't get the immunity on an empty stomach. Feel woozy? Crouch or bring one leg up to push blood back into your brain. Fainting can act as a warrior response, allowing someone to faint but stay alive in battle. A CDC study of fainting with the HPV vaccine found no one fainted in the Buzzy group, but 1/10 did in the "listen to music" group.Meditation was commonly user suggested as a tool for handling needle fear where topical anesthetic was not present at all. Thinking about loved ones and physical touch were also suggested as tools for lowering needle fear during injections.Dedicated COVID-19 webpage here: https://explore.paincarelabs.com/covid-19-vaccination-resourcesBuzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections, and the temporary relief of minor injuries (muscle or tendon aches, splinters, and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion, and muscle tension.Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.

Find Buzzy & VibraCool at shop.paincarelabs.com05:14 Study Referenced - https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab143/6189113#.YGcmfR2zWcc.linkJust as healthcare workers probably had some t-cell immunity against COVID19, illness and vaccination will educate the T-cells to provide some immunity against covid.Pfizer announced 100% efficacy at stopping severe disease in younger age patients. Covid is proving to be more lethal than other diseases that we are already vaccinating children for. Cases are on the rise and the 45-65 demographic is a large number of hospitalizations. This means we're doing a good job at vaccinating older people.Data is getting processed from Dr. Baxter's nasal irrigation study. Patients in the nasal irrigation study had symptoms that lasted for ~4 days compared to ~17 days in a Florida control study.Don't forget to #Vaccinate4Love and find #HackTheVax tips if you aren't a fan of needles.Dedicated COVID-19 webpage here: https://explore.paincarelabs.com/covid-19-vaccination-resourcesBuzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections, and the temporary relief of minor injuries (muscle or tendon aches, splinters, and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion, and muscle tension.Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.

For Buzzy & VibraCool products visit shop.paincarelabs.comBuzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections, and the temporary relief of minor injuries (muscle or tendon aches, splinters, and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion, and muscle tension.Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.